TCL Archive NCIs FY95 Bypass To Justify $3.47 Billion, includes $490 million For Breast Cancer Research May 14, 1993
TCL Archive NIH Reauthorization Compromise Between House and Senate Gives NCI Three Year Authorization Period October 18, 1985
TCL Archive Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia October 31, 2003
TCL Archive In Brief: Visco Elected Chairman of DOD Panel; Breast Cancer Stamp Raises $4.9 Million February 19, 1999
